ACCELERATOR INCUBATOR
OF FONDAZIONE GOLINELLI

YOU CAN JOIN OUR STARTUP INITIATIVES SUBSCRIBING TO THE NEWSLETTER

Join Us
2500+

hours of startup training provided

80+

mentors involved

4.300.000€

invested

32

startup accelerated

Roadmap

G-FACTOR

G-Factor is a reactive environment whose aim is to support new entrepreneurs and researchers with high entrepreneurial potential to become companies able to successfully establish themselves in the market, creating replicable and scalable models. Three years after its establishment, G-Factor has consolidated its position as an accelerator for start-ups in the life sciences sector, while opening up to other vertical sectors.

We invest in innovative start-ups and teams by providing capital and expertise because we believe that the mix of finance and training is crucial to entrepreneurial success.

Read moreMOSTRA MENO

I-Tech Innovation Program 2022 Download report 2021

I-Tech Innovation 2022 is the second edition of the program promoted by Fondazione Golinelli and CRIF. The project is based on 3 Calls for Innovation in the Life Science & Digital Health, FinTech & InsurTech and AgriTech & FoodTech segments. Besides, this year’s edition adds 2 Calls for Plug In in two disruptive areas Industry 4.0, Big Data processing-HPC & Applied Artificial Intelligence (in partnership with Competence Center Bi-Rex) and Social Impact (in partnership with Emil Banca e Gruppo BCC ICCREA).

Subscriptions to the call were open until june 2022 to researchers, independent teams, and startups whith the goal to turn their projects into efficient business models and entities. The selected teams will be granted access to G-Force 2022, the acceleration customized program that offers investments, mentoring meetings and business networking opportunities.

This year’s investment consists of 1.500.000 €, that will be divided among the 10 startups’ batch composed of:

G-FORCE

G-Factor's acceleration program renews its formula in a tailored way, aimed to the I-Tech Innovation Program 2022 startups. Its teams will have access to an innovative acceleration program for young talents that will allow them to grow both in an entrepreneurial and scientific way. G-Force consists of 4 months: the first 2 months are based on intensive activities, which at least two residential weeks are part of. The selected teams will learn how to engage potential industrial partners. This first phase will be followed by 2 months of remote follow-up mentoring activities dedicated to execution. The startups, thanks to tailored meetings and specific training, will learn how to introduce themselves to potential investors and take the following steps for growth and development. The residential activities will mainly take place at BOOM, the new innovation center promoted by CRIF, and also in the G-Factor incubator-accelerator at Opificio Golinelli.

SERVICES & FACILITIES

  • Access to a network of highly qualified mentors and partners
  • Access to a network of investors
  • Legal and patent support
  • Regulatory advice
  • Media Coverage & Communications

Upcoming G-Factor Events

ONLINE EDITION
GRATUITO
Thursday 16 Feb 2023 ore 17:00
REACTORPRO: WEBINAR DI PRESENTAZIONE DEL 16/02
Il 04/02 alle 17 si terrà il secondo webinar di presentazione di ReActorPro, la scuola di imprenditorialità e innovazione promossa da Fondazione Golinelli, in collaborazione con G-Factor, per dottorande e dottorandi, assegniste e assegnisti, giovani ricercatrici e ricercatori, scienziate e scienziati con idee innovative e dall’elevato potenziale di crescita.

image Ciclo di appuntamenti
image Impresa
See all

Network

We collaborate with dozens of entrepreneurs, teachers and managers with different specializations and professional backgrounds to cover all the needs of accelerated startups: from product development to business storytelling, from IP to negotiation, from hard skills to soft skills.

Our industrial partners are important international players in the world of life sciences operating in different business areas: from pharmaceutical to medical devices, from biotech to data science. Together with our industrial partners we help startups to create sustainable and scalable businesses.

Alfasigma
CHIESI
Dompé
IQVIA Italia
B. Braun Avitum Italy
E-Novia
SIFI
Jacobacci & Partners
Bugnion
PQE
Gianni & Origoni
Bormioli Pharma
CerealDocks
Previous Next
Alfasigma
CHIESI
Dompé
IQVIA Italia
B. Braun Avitum Italy
E-Novia
SIFI
Jacobacci & Partners
Bugnion
PQE
Gianni & Origoni
Bormioli Pharma
CerealDocks
Previous Next

BPER
Bi-Rex
Emil Banca
Gruppo BBC Iccrea
BPER
Bi-Rex
Emil Banca
Gruppo BBC Iccrea
Previous Next

Our network is enriched by the presence of research centers, startups, companies and universities that make innovation their daily mission.

Invitalia
InnovUp
Arter
Iner
ClustEr Health
IIT
CNR - Istituto di Farmacologia Traslazionale
Fondazione ANT
Bi-Rex
H-Farm
Vittoriahub
Zambon
STARTUP MARATHON
AREA SCIENCE PARK
Previous Next
Invitalia
InnovUp
Arter
Iner
ClustEr Health
IIT
CNR - Istituto di Farmacologia Traslazionale
Fondazione ANT
Bi-Rex
H-Farm
Vittoriahub
Zambon
STARTUP MARATHON
AREA SCIENCE PARK
Previous Next

We work together with some of the main Italian institutions to accompany our startups on their growth path.

CDP Venture Capital – Fondo Nazionale Innovazione
Unicredit Start Labs
Panakes Partners
IAG - Italian Angels for Growth
Indaco Venture Partners SGR
Claris Ventures
Vertis
IBAN - ITALIAN BUSINESS ANGEL NETWORK
Banca di Bologna
DoorWay
Mamacrowd - Siamo Soci
Club degli Investitori
Emil Banca
HTH Venture
BacktoWork24
OCC, Overseas Capital Contest
Angels4Women
Four Partners
Seed money
A11vENTURE
Previous Next
CDP Venture Capital – Fondo Nazionale Innovazione
Unicredit Start Labs
Panakes Partners
IAG - Italian Angels for Growth
Indaco Venture Partners SGR
Claris Ventures
Vertis
IBAN - ITALIAN BUSINESS ANGEL NETWORK
Banca di Bologna
DoorWay
Mamacrowd - Siamo Soci
Club degli Investitori
Emil Banca
HTH Venture
BacktoWork24
OCC, Overseas Capital Contest
Angels4Women
Four Partners
Seed money
A11vENTURE
Previous Next

Startups

124 applications have been received for the first call of G-Factor, Life Sciences Innovation : 30 of these have reached the final stage and 10 have been selected to participate in the acceleration process which has end in December 2019 with the awaited Investor Day. Each Startup has received an investment of €100,000 €

medtech

BCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.

Website
medtech

Adam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled

Website
bioengineering

Complexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.

Website
medtech

Diamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.

Website
bioengineering

eVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.

Website
medtech

Genoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.

Website
medtech

Holey has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.

Website
medtech

MgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.

medtech

P4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.

medtech

RELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.

137 applications have been received for the second call of G-Factor, Life Sciences Innovation 2020: 24 of these have reached the final stage and 5 have been selected to participate in the acceleration process which will end in December 2020 with the awaited Investor Day. Each Startup will receive an investment of €125,000 of which € 90,000 of liquidity and € 35,000 in kinds.

nutraceutica

Thanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.

Website
medtech

Innovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.

Website
medtech

An innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.

Website
pharma

Micro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.

Website
medtech

RECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.

Website

209 applications received for the I-Tech Innovation Program call launched by Fondazione Golinelli and CRIF in three areas: Life Sciences/Digital Health (3 startups selected), Fintech/Insurtech (2 startups selected), and FoodTech/Agritech (2 startups selected). 1 million euros will be granted for the startups themselves

Lifescience/Digital health

created with the aim of experimenting a new compound called DDC#1 on humans for Acute Myeloid Leukemia and COVID-19 fighting

Lifescience/Digital health

goes to market through a device that makes the medicines’ selection process faster and more effective through the laboratory plastic creation of an environment that looks like the tissues of the human body and indeed similar to the context in which the medicine will work

Lifescience/Digital health

is based on the use of polymeric retinal prostheses for vision recovery, subsequent to a loss due to retinal degeneration induced by several diseases (i.e. retinitis pigmentosa).

Fintech/Insurtech

EvenFi is the crowdlending platform that offers investors the opportunity to earn by investing in growth projects of startups and SMEs.

Website
Fintech/Insurtech

allows consumers to choose and select the innovative financial services that best comply with their needs. Its services let suppliers access a single distribution channel that guarantees them to contain acquisition costs.

Website
Foodtech/Agritech

is the first virtual agricultural community based on two pillars: small producers and final consumers. It is also a marketplace for direct sales of agricultural products.

Website
Foodtech/Agritech

is a unified data analysis platform that is fully automated and able to extract information from satellite images. By removing the technological barriers in the use of satellite data, the platform allows to transform satellite images into geospatial information by offering data the farmer needs in the simplest way to read them.

Website

247 applications received for the I-Tech Innovation Program call launched by Fondazione Golinelli and CRIF in five areas: Life Sciences/Digital Health (3 startups selected), Fintech/Insurtech (2 startups selected), FoodTech/Agritech (1 startups selected), Industry 4.0 (2 startups selected) and Social Impact (2 startups selected). 1,5 million euros has been invested for the startups.

Lifescience/Digital health

AEQUIP, a startup and spin-off of the Politecnico di Torino, develops diagnostic support tools in the field of Digital Pathology, which integrate Artificial Intelligence with mathematical-statistical parameters in a new proprietary approach called MDI: Mathematical Driven Intelligence.

Website
Lifescience/Digital health

Docunque is a medical practice management software that helps doctors in their daily work, improving prescriptive appropriateness and acting on citizen prevention, using artificial intelligence algorithms. Docunque innovates from the bottom up by intervening in what is often the only professional tool that doctors use every day.

Website
Lifescience/Digital health

UCme Bioscience is developing a new anti-angiogenic antibody of its own invention for the therapy of diseases with a neovascular component, such as diabetic retinopathy and age-related macular degeneration, for which the treatments currently used do not lead to a complete and lasting cure. Since angiogenesis is also involved in the development of cancer, important applications of the product are also expected in this field.

Foodtech/Agritech

Agrobit develops and sells innovative services and apps for digital farming. The app iAgro allows the farmer to transform his smartphone into a decision support system to map tree crops and optimize phytosanitary treatments, in a simple and scalable way. The service of remote sensing by drones provides the farmer with a complete mapping of his fields and crops in order to optimize the use of fertilizers, agrochemicals and water.

Website
Fintech/Insurtech

Mopso is a regtech company that develops two software to deal with anti-money laundering regulations, Brain and Amlet. Brain is a risk assessment tool and helps banks find suspicious transactions. Amlet makes due diligence data 'portable' and reusable within an ecosystem of intermediaries, simplifying the onboarding process. Mopso can handle all the complexities within the financial world, as they use the largest and most sophisticated ontology, FIBO (Financial Industry Business Ontology), together with AML ontology.

Website
Fintech/Insurtech

Notarify solve several problems and risks related to the storage, sharing and signing of files. Notarify, in fact, is the first platform for the management of the entire lifecycle of documents with Blockchain validation, i.e. the so-called 'notarization', which allows to obtain a certain date and a proof of immutability of the content.

Website
Industry 4.0

AdapTronics makes logistics more sustainable on Earth and in Space by reinventing how robots grasp objects of any shape, size and material thanks to a proprietary thin-film technology that becomes adhesive when electrically activated, with an impressive force density, irrelevant weight and minimal energy consumption.

Website
Industry 4.0

Astreo is an IoT (Internet of Things) start-up. Adopting innovative technologies, such as Blockchain, Artificial Intelligence, LPWAN and 5G networks, Astreo aspires to build a software platform, which allows to develop smart city and smart industry applications. Using the concept of decentralization, Astreo will provide the infrastructure, devices and web platform for a fully working IoT network.

Social Impact

Heaple brings to market a cloud platform where patients play therapeutic games through an app from home. The neuropsychologist schedules and analyses the cognitive therapy with the assistance of artificial intelligence algorithms using a dedicated dashboard. The goal is to help people with cognitive impairment to achieve self-sufficiency through a platform accessible to everyone.

Website
Social Impact

Justep is a medical device that aims to replace the white cane for the blind and visually impaired and to solve the problem of navigation. Justep thanks to its artificial intelligence works with a lidar sensor and a camera that detect and recognize any obstacle in front of the user, suggesting the best path to reach his/her destination.

Website

medtech

BCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.

Sito web
medtech

Adam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled

Sito web
bioengineering

Complexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.

Sito web
medtech

Diamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.

Sito web
bioengineering

eVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.

Sito web
medtech

Genoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.

Sito web
medtech

Holey has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.

Sito web
medtech

MgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.

medtech

P4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.

medtech

RELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.

nutraceutica

Thanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.

Sito web
medtech

Innovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.

Sito web
medtech

An innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.

Sito web
pharma

Micro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.

Sito web
medtech

RECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.

Sito web
lifescience

created with the aim of experimenting a new compound called DDC#1 on humans for Acute Myeloid Leukemia and COVID-19 fighting

lifescience

goes to market through a device that makes the medicines’ selection process faster and more effective through the laboratory plastic creation of an environment that looks like the tissues of the human body and indeed similar to the context in which the medicine will work

lifescience

is based on the use of polymeric retinal prostheses for vision recovery, subsequent to a loss due to retinal degeneration induced by several diseases (i.e. retinitis pigmentosa).

fintech

EvenFi is the crowdlending platform that offers investors the opportunity to earn by investing in growth projects of startups and SMEs.

Sito web
fintech

allows consumers to choose and select the innovative financial services that best comply with their needs. Its services let suppliers access a single distribution channel that guarantees them to contain acquisition costs.

Sito web
agritech

is the first virtual agricultural community based on two pillars: small producers and final consumers. It is also a marketplace for direct sales of agricultural products.

Sito web
agritech

is a unified data analysis platform that is fully automated and able to extract information from satellite images. By removing the technological barriers in the use of satellite data, the platform allows to transform satellite images into geospatial information by offering data the farmer needs in the simplest way to read them.

Sito web
lifescience

AEQUIP, a startup and spin-off of the Politecnico di Torino, develops diagnostic support tools in the field of Digital Pathology, which integrate Artificial Intelligence with mathematical-statistical parameters in a new proprietary approach called MDI: Mathematical Driven Intelligence.

Sito web
lifescience

Docunque is a medical practice management software that helps doctors in their daily work, improving prescriptive appropriateness and acting on citizen prevention, using artificial intelligence algorithms. Docunque innovates from the bottom up by intervening in what is often the only professional tool that doctors use every day.

Sito web
lifescience

UCme Bioscience is developing a new anti-angiogenic antibody of its own invention for the therapy of diseases with a neovascular component, such as diabetic retinopathy and age-related macular degeneration, for which the treatments currently used do not lead to a complete and lasting cure. Since angiogenesis is also involved in the development of cancer, important applications of the product are also expected in this field.

agritech

Agrobit develops and sells innovative services and apps for digital farming. The app iAgro allows the farmer to transform his smartphone into a decision support system to map tree crops and optimize phytosanitary treatments, in a simple and scalable way. The service of remote sensing by drones provides the farmer with a complete mapping of his fields and crops in order to optimize the use of fertilizers, agrochemicals and water.

Sito web
fintech

Mopso is a regtech company that develops two software to deal with anti-money laundering regulations, Brain and Amlet. Brain is a risk assessment tool and helps banks find suspicious transactions. Amlet makes due diligence data 'portable' and reusable within an ecosystem of intermediaries, simplifying the onboarding process. Mopso can handle all the complexities within the financial world, as they use the largest and most sophisticated ontology, FIBO (Financial Industry Business Ontology), together with AML ontology.

Sito web
fintech

Notarify solve several problems and risks related to the storage, sharing and signing of files. Notarify, in fact, is the first platform for the management of the entire lifecycle of documents with Blockchain validation, i.e. the so-called 'notarization', which allows to obtain a certain date and a proof of immutability of the content.

Sito web
industry

AdapTronics makes logistics more sustainable on Earth and in Space by reinventing how robots grasp objects of any shape, size and material thanks to a proprietary thin-film technology that becomes adhesive when electrically activated, with an impressive force density, irrelevant weight and minimal energy consumption.

Sito web
industry

Astreo is an IoT (Internet of Things) start-up. Adopting innovative technologies, such as Blockchain, Artificial Intelligence, LPWAN and 5G networks, Astreo aspires to build a software platform, which allows to develop smart city and smart industry applications. Using the concept of decentralization, Astreo will provide the infrastructure, devices and web platform for a fully working IoT network.

socialimpact

Heaple brings to market a cloud platform where patients play therapeutic games through an app from home. The neuropsychologist schedules and analyses the cognitive therapy with the assistance of artificial intelligence algorithms using a dedicated dashboard. The goal is to help people with cognitive impairment to achieve self-sufficiency through a platform accessible to everyone.

Sito web
socialimpact

Justep is a medical device that aims to replace the white cane for the blind and visually impaired and to solve the problem of navigation. Justep thanks to its artificial intelligence works with a lidar sensor and a camera that detect and recognize any obstacle in front of the user, suggesting the best path to reach his/her destination.

Sito web

Team

Antonio Danieli

Vice President, General Manager and Board Member
@ Fondazione Golinelli
CEO @ G-Factor Incubator-Accelerator

Federica Tadini

GM General manager

f.tadini@fondazionegolinelli.it
Benedetta D’Oria

CFO Chief Financial Officer

b.doria@fondazionegolinelli.it
Vanessa Mazzei

Project leader

v.mazzei@fondazionegolinelli.it
Christian Lussafi

Analyst

c.lussafi@fondazionegolinelli.it
Silvia Cozzi

Program manager

s.cozzi@fondazionegolinelli.it
Giulia Mastandrea

Junior program manager

g.mastandrea@fondazionegolinelli.it
Francesco Castellana

Media manager

f.castellana@fondazionegolinelli.it

BUSINESS AND SCIENTIFIC REFEREES

Antonio Falcone

Independent Mentor

Raffaella Spagnuolo

Resident Scientific Referee

Gianluca Sferrazza

Independent Scientific Referee

Ilan Misano

Independent Scientific Referee

Emanuele Panza

Independent Scientific Referee

Francesco Lescai

Independent Scientific Referee

Giulia Falcone

Independent Business Referee

Carlo Tassi

Independent Business Referee

Emanuele D’Erme

Independent Mentor

Follow us

Contact Us

How can we help you?

Adress and VAT Number

Via Paolo Nanni Costa, 20
40133 Bologna
VAT number 03710391206